Piper Sandler Reiterates Overweight on Nutanix, Raises Price Target to $75

Benzinga Newsdesk www.benzinga.com Positive 67.4%

Neg 0% Neu 0% Pos 67.4%

Piper Sandler analyst James Fish reiterates Nutanix (NASDAQ:NTNX) with a Overweight and raises the price target from $60 to $75.